Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · Real-Time Price · USD

6.44

-0.38 (-5.57%)

At close: Jun 18, 2026, 4:00 PM EDT

6.32

-0.12 (-1.86%)

After-hours: Jun 18, 2026, 4:00 PM EDT

Champions Oncology Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Cash & Equivalents	7.13	9.79	2.62	10.12	9.01	4.69
Cash & Short-Term Investments	7.13	9.79	2.62	10.12	9.01	4.69
Cash Growth	158.79%	273.76%	-74.13%	12.34%	92.17%	-43.81%
Accounts Receivable	-	-	9.53	8.01	9.51	6.99
Other Current Assets	0.99	1.37	1.5	1.33	1.14	0.96
Total Current Assets	20.19	22.36	13.64	19.46	19.66	12.63
Net Property, Plant & Equipment	7.73	9.46	11.97	14.5	15.36	14.61
Goodwill	0.34	0.34	0.34	0.34	0.34	0.34
Other Long-Term Assets	0.2	0.2	0.19	0.02	0.02	0.02
Total Assets	28.45	32.34	26.13	34.31	35.38	27.59
Accounts Payable	5.73	4.25	5.8	5.33	2.87	1.89
Accrued Expenses	3.35	2.56	2.16	2.27	2.41	2.23
Current Portion of Leases	1.53	1.47	1.34	1.21	1.05	0.82
Unearned Revenue	10	15.44	12.09	12.78	11.07	6.26
Other Current Liabilities	0.08	0.14	0.15	0.15	0.07	-
Total Current Liabilities	20.68	23.85	21.54	21.73	17.48	11.2
Long-Term Leases	3.37	4.63	6.09	7.39	8.41	8.78
Other Long-Term Liabilities	0.03	0.09	0.4	0.55	0.39	0.18
Total Long-Term Liabilities	3.39	4.72	6.49	7.94	8.8	8.96
Total Liabilities	24.07	28.57	28.04	29.68	26.28	20.16
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Treasury Stock	-0.71	-0.71	-0.71	-0.07	-	-
Additional Paid-in Capital	85.38	84.36	83.38	82.01	81.06	79.95
Retained Earnings	-80.4	-79.89	-84.59	-77.32	-71.98	-72.53
Total Common Shareholders' Equity	4.28	3.77	-1.9	4.64	9.1	7.43
Minority Interest	0.1	-	-	-	-	-
Shareholders' Equity	4.38	3.77	-1.9	4.64	9.1	7.43
Total Liabilities & Equity	28.45	32.34	26.13	34.31	35.38	27.59
Total Debt	4.89	6.11	7.43	8.6	9.47	9.6
Net Cash (Debt)	2.23	3.68	-4.81	1.52	-0.46	-4.91
Net Cash Growth	-39.32%	-	-	-	-	-
Net Cash Per Share	0.16	0.26	-0.35	0.11	-0.03	-0.34
Book Value	4.28	3.77	-1.9	4.64	9.1	7.43
Book Value Per Share	0.31	0.26	-0.14	0.34	0.64	0.51
Tangible Book Value	3.95	3.44	-2.24	4.3	8.76	7.09
Tangible Book Value Per Share	0.28	0.24	-0.17	0.32	0.62	0.49

SEC Filings: 10-K · 10-Q